12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Friday's intraday session, several healthcare stocks experienced significant movements. Adial Pharmaceuticals, BioVie, Cardiff Oncology, Myomo, Altamira Therapeutics, and MSP Recovery were among the gainers, with increases ranging from 24.11% to 58.8%. Conversely, Scilex Holding, Precision BioSciences, DermTech, Vivani Medical, Gritstone Bio, and Humacyte saw declines between 20.81% and 36.4%. Notably, Cardiff Oncology and DermTech released their Q4 earnings reports yesterday.
March 01, 2024 | 5:35 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
DermTech shares decreased by 32.12% to $0.87, market cap at $29.7 million, following their Q4 earnings report.
DermTech's significant stock price decline post-Q4 earnings suggests the results may have disappointed investors, leading to negative sentiment.
CONFIDENCE 95
IMPORTANCE 85
RELEVANCE 95
POSITIVE IMPACT
Adial Pharmaceuticals stock increased by 58.8% to $3.24, with a market value of $5.3 million.
The significant increase in ADIL's stock price indicates strong investor interest, potentially due to positive developments or expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
BioVie stock increased by 48.38% to $1.84, with a market cap of $73.3 million.
BioVie's substantial stock price increase suggests positive market sentiment, possibly driven by favorable news or company performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Cardiff Oncology shares increased by 30.72% to $2.31, market value at $103.0 million, following their Q4 earnings report.
The positive reaction to Cardiff Oncology's Q4 earnings report suggests the results exceeded market expectations, driving the stock price up.
CONFIDENCE 95
IMPORTANCE 85
RELEVANCE 95